Noel Thomas Doheny

Epigenomics, Inc. operates as a molecular diagnostics company. It focuses on blood-based detection of cancers using its proprietary DNA methylation technology. The firm develops and commercializes blood-based diagnostic products across multiple cancer indications with high medical need. The company was founded in 1997 and is headquartered in Seattle, WA.

Cernostics, Inc. develops and commercializes cancer diagnostic tests. Its technology is based on a systems approach to evaluating tissues via anatomic pathology and simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide while preserving tissue structure. The company was founded in 2008 by Michel Nederlof and Rebecca Critchley-Thorne and is headquartered in Pittsburgh, PA.

Integrated Nano-Technologies, Inc. provides healthcare services. The firm offers food testing, veterinary diagnostics, medical diagnostics, environmental testing, research and forensics. The company was founded in 2000 and is headquartered in Henrietta, NY.

QIAGEN Sciences, Inc. manufactures chemical products. It offers assay technologies and products in areas such as pre-analytical sample preparation and assay solutions in research for life sciences, applied testing and molecular diagnostics. The company's products are sold to academic research markets, to pharmaceutical and biotechnology companies, to applied testing customers (such as in forensics, veterinary, biodefense and industrial applications) as well as to molecular diagnostics laboratories. QIAGEN Sciences was founded in January, 2002 and is located in Germantown, MD